Law Firm Continues Investigation into Inspire Medical Directors and Officers

Law firm Kahn Swick & Foti (KSF) announced it is continuing its investigation into the officers and directors of Inspire Medical Systems Inc. (NYSE: INSP). The firm's probe is examining potential breaches of fiduciary duty or other violations of state and federal laws by the company's leadership.

The investigation stems from Inspire Medical's disclosure in August 2025 that the launch of its Inspire V device would face an "elongated timeframe." The company cited undisclosed issues, including incomplete training and onboarding at medical centers, delayed software updates for claims, and poor demand due to excess inventory. This led Inspire Medical to slash its 2025 earnings guidance by over 80%.

Following the announcement, a securities class action lawsuit was filed against the company and certain executives, alleging violations of federal securities laws. The case has since been transferred from the U.S. District Court for the Southern District of New York to the District of Minnesota and remains ongoing.

KSF is seeking individuals with information that could aid their investigation or long-term Inspire shareholders who wish to discuss their legal rights. The law firm specializes in securities litigation and has experience representing investors in cases of corporate misconduct.